Dublin, Feb. 21, 2023 (GLOBE NEWSWIRE) -- The "Glucose Monitoring Devices: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Glucose Monitoring Devices estimated at US$13.1 Billion in the year 2022, is projected to reach a revised size of US$19.2 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2022-2030.
Self-Monitoring Devices, one of the segments analyzed in the report, is projected to record 4% CAGR and reach US$11.3 Billion by the end of the analysis period.
Taking into account the ongoing post pandemic recovery, growth in the Continuous Blood Glucose Monitoring Devices segment is readjusted to a revised 6.2% CAGR for the next 8-year period.
The U.S. Market is Estimated at $3.6 Billion, While China is Forecast to Grow at 8% CAGR
The Glucose Monitoring Devices market in the U.S. is estimated at US$3.6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$4.1 Billion by the year 2030 trailing a CAGR of 8% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.6% and 5.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.
Select Competitors (Total 32 Featured) -
- Abbott Diabetes Care, Inc.
- ACON Laboratories, Inc.
- AgaMatrix, Inc.
- Alive Technologies Pty. Ltd.
- ARKRAY, Inc.
- Ascensia Diabetes Care Holdings AG
- B. Braun Melsungen AG
- Beurer GmbH
- Dexcom, Inc.
- GlySens Inc.
- LifeScan, Inc.
- Medtronic plc
- Nova Biomedical Corporation
- Omron Healthcare Co., Ltd.
- Roche Diagnostics
- Senseonics Holdings, Inc.
- Terumo Corporation
- Trividia Health, Inc.
- Ypsomed Holding AG
What`s New for 2023?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Report Metrics:
Report Attribute | Details |
No. of Pages | 268 |
Forecast Period | 2022 - 2030 |
Estimated Market Value (USD) in 2022 | $13.1 Billion |
Forecasted Market Value (USD) by 2030 | $19.2 Billion |
Compound Annual Growth Rate | 4.9% |
Regions Covered | Global |
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Glucose Monitoring Devices: Enabling Easier and Efficient Monitoring of the Global Diabetes Epidemic
- Growth Drivers in a Nutshell
- Recent Market Activity
- Glucose Monitoring Undergoes Notable Transformation over the Years: An Evolutionary Scan
- Evolution of Diabetes Testing over the Years with Key Features in Each Period
- Diabetes Incidence Reaching Epidemic Proportions Worldwide: Foundation for Market Growth
- Diabetes: One of the Leading Causes of Death Globally
- Diabetes Incidence and Prevalence by Region/Country
- Global Market Outlook
- Developed Countries are Dominant Markets, while Developing Countries Spearhead Market Growth
- Glucose Monitoring Devices - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Growing Popularity of Smart, Compact, Digital, Ergonomic, and Wireless Glucose Monitors Drive Healthy Market Growth
- Select Disruptive Glucose Monitors Promising Reduced Pain, Lesser Data Load, and Zero Worries
- Innovative Smart Glucometers for Sugar Monitoring
- Need for Real-Time Glucose Sensing and Monitoring Drive Strong Demand for Minimally-Invasive CGM Devices
- Myriad Benefits of CGMs
- CGM Market Gradually Breaks through Barriers to Adoption
- Intensive Care Units: A Highly Promising Market for CGMs
- Key Challenges Hampering Widespread Adoption of CGM Systems
- Despite Competition from CGM Systems, SGM Devices Continue to Dominate Sales
- Blood Glucose Test Strips: The Largest Segment
- Cost: The Ultimate Factor Favoring Growth in Demand for Blood Glucose Monitoring Systems
- Self-Monitoring/Household Blood Glucose:Sustaining Growth in Demand
- Key Trends in the Glucose Meter/Monitoring Systems
- Smartphone Penetration Favors SMBG Market
- Barriers to Adoption of New Technology in BGM Products
- Accuracy Issues Plague Blood Glucose Meters Market
- Advancements in Glucose Monitoring Devices Offers a New Ray of Hope
- Undiagnosed Diabetes: A Major Healthcare Challenge Offering Huge Untapped Potential
- Undiagnosed Diabetics: More Prone to Cardiovascular Diseases
- Increased Vulnerability of Diabetics to Various Health Complications Drives the Need for Timely Glucose Monitoring
- Non-Insulin-Dependent Diabetes Mellitus (NIDDM) Lead to Cardiovascular Complications
- Higher Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion
- Demographic Statistics of the Global Aging Populace: Unfurling the Market Potential
- Increasing Healthcare Expenditure Boosts Demand for SGM and CGM Devices
- Increasing Obesity Levels Underpins Market Growth
- K'Track: Discreet and Painless Glucose- Monitoring Wearable
- The Sugar iQ App Provide Predictive Diabetes Care
- DIABNEXT CLIPSULIN: World's First A.I Tool for Diabetes
- e-mosquito CGM Device
- FreeStyle Libre Flash Glucose Monitoring System
- MyDario Mobile Data Management Platform
- The New Handheld RL-BGM Device
- TOUCH TG
- Pocket-Sized Gadgets
- Digital Contact Lenses
- Gamification
- Leveraging Big Data
- Digital Tattoos
- OneTouch Verio Flex Monitoring System
- Artificial Pancreas System (APS): The Next Big Thing in Glucose Monitoring
- The First-of-its-Kind Artificial Pancreas by Medtronic
- Non-invasive, Acetone Detecting Breathalyzer for Glucose Testing
- Nanotechnology-based Breathalyzer for Non-Invasive Glucose Monitoring
- EMG 1000: Needle-free Device for Glucose Monitoring
- Glucase: Smartphone Case with Glucose Testing Kit
- Painless Diabetes Monitoring Using NFC Technology
- GlucoSense: Laser Device for Non-invasive Monitoring of Glucose Levels
- ClearPath DS-120: Enabling Early Detection of Diabetes & Prediabetes
- NoStripT Technology: Eliminating Need for Individual Test Strips
- Other Innovative and Advanced Glucose Monitoring Systems
- Notable Early-stage Investigative Glucose Monitoring Devices
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/mockpw
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment